Owkin: How AI Is Rewriting the Rules of Drug Development
What is Owkin? Owkin is a tech-bio company that applies agentic and ...
Insitro: How AI-First Biotech Is Slashing R&D Timelines and Costs for Pharma Leaders
What is Insitrio? Insitro combines large-scale, multimodal biological data generation (automated cellular ...
Iktos: How Pharma Leaders Use AI to Design Drugs Faster and Cut Discovery Costs in Half
What is Iktos? Iktos (Makya & Spaya) combines two complementary platforms for ...
Vecura: How AI is Rewriting the Rules of Drug Discovery
What is Vecura? Vecura is Nanyang Biologics’ (NYB’s) proprietary, as-a-service AI platform ...
BenchSci: How AI is Slashing Drug Discovery Timelines by Unlocking Hidden Data
What is BenchSci? BenchSci ASCEND™ platform uses multi-modal AI—including scientific LLMs and ...
BenevolentAI: How This AI Platform is Rewriting the Rules of Pharma Innovation
Overview: How BenevolentAI’s AI‑Driven Drug Discovery Platform Transforms Pharma R&D Traditionally, getting ...
Atomwise: The AI Powering Smarter Small Molecule Discovery New
What is Atomwise? Atomwise is a pioneering artificial intelligence tool designed to ...
Insilico’s AI Just Designed a Drug from Scratch: Faster Than Any Human Team Could
What is Insilico? Insilico Medicine’s Life Star is a fully automated, AI-powered ...